Trevena announced that Mark Corrigan, M.D. has been appointed to the Company’s Board of Directors, effective July 18 2023. Dr. Corrigan has served as Chief Executive Officer of Tremeau Pharmaceuticals, a pharmaceutical company that Dr. Corrigan co-founded, since January 2023.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on TRVN:
- Trevena, Inc. Appoints Mark Corrigan, M.D. to Board of Directors
- Trevena announces OLINVYK data from ARTEMIS study
- Trevena Announces New Topline OLINVYK Data Highlighting Reduced Cost per Admission from ARTEMIS Real-World Outcomes Study
- Trevena Regains Compliance with Nasdaq Listing and Reaffirms Expected Near-Term Milestones
